Puerto Rico begins inoculation with third dose to people over 65 years of age
Puerto Rico begins inoculation with third dose to people over 65 years of age

San Juan, (EFE) – The health authorities of Puerto Rico began this Friday the process of inoculating people over 65 years of age with the third dose of the Pfizer-BioNTech covid-19 vaccine.

The director of VOCES: Coalition for Immunization and Health Promotion, Lilliam Rodríguez, reported that the vaccination of this group with the third dose began in the Municipality of Cataño and the organization’s centers throughout the island.

Rodríguez showed his satisfaction for the number of people over 65 who registered today in the municipality of Cataño to be inoculated with a third dose.

The United States Food and Drug Administration (FDA) approved, on August 10, the administration of third doses to people with serious illnesses who are more prone to contracting infections or who do not have a response with guarantees of their bodies after receiving two doses of the Pfizer-BioNTech or Moderna vaccines.

The agency, last Wednesday, approved a third booster dose of the Pfizer-BioNTech vaccine for people over 65 and in groups at high risk of infection.

Vaccination in the municipality of Cataño will take place today and tomorrow in the Bahía Vivair area without an appointment and free of charge.

The objective of carrying it out in Cataño responds to the attempt to increase the percentage of vaccinated people in that municipality, since only 49% of its population has the complete series of two doses.

The CDC placed Puerto Rico at the moderate level of community transmission of covid-19, as revealed this Friday by the island’s Secretary of Health, Carlos Mellado, after several weeks at the red (high) level.

The governor of the island, Pedro Pierluisi, pointed out that 70% of the island’s population is vaccinated, placing the island in the first places in relation to the continental United States.

Currently the positivity rate is 5.2 percent in Puerto Rico.

Leave a Reply